Nov 30, 2021 / 01:30PM GMT
Operator
Hello and welcome to the TG Therapeutics Update Call. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Jenna Bosco, Senior Vice President, Corporate Communications. Please go ahead, Jenna.
Jenna Bosco - TG Therapeutics, Inc. - VP of IR & Senior VP of Corporate Communications
Thank you. Good morning, and thank you all for joining us. I'm Jenna Bosco, and I welcome you all to our conference call today. Following our safe harbor statement, Michael Weiss, our Chairman and Chief Executive Officer, will discuss the regulatory updates announced this morning and then turn the call over to the operator to begin the Q&A session.
Before we begin, I'd like to remind everyone that various remarks that we make about our future expectations, plans and prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. TG cautions that these forward-looking statements are subject to risks that may cause our actual results to
TG Therapeutics Inc Regulatory Updates Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers